Skip to main content
Icade logo

Icade — Investor Relations & Filings

Ticker · ICAD ISIN · FR0000035081 LEI · 969500UDH342QLTE1M42 PA Real estate activities
Open in API
Filings indexed 1,088 across all filing types
Latest filing 2023-03-15 Capital/Financing Update
Country FR France
Listing PA ICAD

About Icade

https://www.icade.fr/en/

Icade is an integrated real estate company that operates as both a property investor and a property developer. The company's investment division focuses on a portfolio of commercial properties, including offices and business parks, as well as healthcare facilities. As a developer, Icade designs, builds, and manages a diverse range of assets, from residential properties to large-scale urban projects. A central element of its strategy is the creation of innovative and sustainable real estate solutions, with an emphasis on developing low-carbon buildings and functional urban spaces for future communities.

Recent filings

Filing Released Lang Actions
PR Icade - Standard & Poor's affirms Icade's BBB+ rating with a stable outlook
Capital/Financing Update Classification · 1% confidence The document is a press release dated March 15, 2023, announcing that Standard & Poor's affirmed ICADE's BBB+ rating with a stable outlook following a recent transaction announcement. It details expected financial ratios (LTV, Net Debt/EBITDA) for the end of 2023 and confirms that 2023 guidance and dividend policy remain unchanged, while also mentioning a potential future special dividend related to the transaction. This content is a direct announcement of financial performance expectations, rating agency actions, and dividend policy updates, which aligns best with an Earnings Release (ER) or potentially a Capital/Financing Update (CAP) due to the focus on leverage ratios and dividends. However, since it is a formal press release summarizing key financial metrics and outlook post-event (rather than the full quarterly report), ER is the most appropriate fit for initial financial result communication, even though it's not explicitly labeled 'Q4 Results'. It is not a full report (10-K or IR), nor is it a transcript (CT) or a presentation (IP). Given the focus on rating affirmation and forward-looking financial metrics, ER is the strongest classification.
2023-03-15 English
CP Icade - Confirmation par S&P du rating BBB+ perspective stable
Capital/Financing Update Classification · 1% confidence The document is a 'COMMUNIQUÉ DE PRESSE' (Press Release) dated March 15, 2023. It primarily discusses the confirmation of the company's BBB+ rating by Standard & Poor's following a major transaction (sale of Icade Santé stake). It details expected impacts on key financial ratios (LTV, Debt/EBITDA) and confirms the 2023 guidance and dividend policy based on this expected transaction. This content—financial outlook, rating confirmation, and dividend policy updates following a major event—is characteristic of an Earnings Release (ER) or a Management Discussion & Analysis (MDA) section, but since it is a short press release format announcing key financial outcomes and forward-looking statements related to performance and capital structure following a significant event, it aligns best with an Earnings Release (ER) which provides initial highlights, or potentially a Capital/Financing Update (CAP) due to the heavy focus on debt ratios and transaction impacts. Given the confirmation of rating and guidance updates, ER is the most appropriate fit for a high-level financial announcement. It is not a full 10-K, IR, or a simple dividend notice (DIV). It is too specific for a general RNS.
2023-03-15 French
PR - ICADE AND PRIMONIAL REIM SIGN AN EXCLUSIVITY AGREEMENT FOR THE ACQUISITION OF ICADE’S STAKE IN ICADE SANTÉ
Earnings Release Classification · 1% confidence The document is a press release dated March 13, 2023, announcing a significant corporate transaction: an exclusivity agreement for the sale of ICADE's stake in ICADE SANTÉ to PRIMONIAL REIM. This involves asset disposal, capital structure changes, and potential dividend implications. It is not a formal regulatory filing like a 10-K or an IR, nor is it a standalone Audit Report (AR) or a general Earnings Release (ER). It details a major corporate action related to financing and capital structure (sale of a major division/stake). This aligns best with the 'Capital/Financing Update' (CAP) category, as it describes a multi-stage transaction designed to unlock value, reduce debt, and result in special dividends. It is also announcing a conference call for discussion, which is common for major corporate events, but the core content is the transaction itself. It is not a Call Transcript (CT) but an announcement *about* a call. It is not a Management Discussion & Analysis (MDA) as it is a press release focused on a specific deal, not a comprehensive review of operations. Therefore, CAP is the most appropriate classification. FY 2023
2023-03-13 English
CP - ICADE ET PRIMONIAL REIM SIGNENT UN ACCORD D'EXCLUSIVITE PORTANT SUR LE RACHAT DE LA PARTICIPATION D'ICADE DANS ICADE SANTE
M&A Activity Classification · 1% confidence The document is a 'COMMUNIQUÉ DE PRESSE' (Press Release) dated March 13, 2023, detailing a significant corporate transaction: an exclusivity agreement between ICADE and PRIMONIAL REIM regarding the sale of ICADE's stake in ICADE SANTE. It outlines the structure, financial implications (including expected exceptional dividends), and future steps. Crucially, it concludes by announcing a 'Conférence Call' scheduled for the next day (March 14, 2023) with access details (webcast link, phone numbers, password). A press release announcing a major transaction and immediately followed by details for an investor/analyst call strongly suggests this is an Earnings Release (ER) or a related event announcement, but since it focuses on a specific M&A/financing event rather than periodic financial results highlights, it fits best under Capital/Financing Update (CAP) or potentially a Regulatory Filing (RNS) if it were purely mandatory disclosure. However, the content is a detailed announcement of a major financing/transaction (sale of a major asset leading to cash generation and dividend obligation). Given the options, 'Capital/Financing Update' (CAP) is the most specific fit for an announcement detailing a major asset sale intended to generate significant cash and dividends. It is not a full report (10-K, IR), nor is it just a notice of a report publication (RPA).
2023-03-13 French
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL" (Monthly Information Relative to the Total Number of Shares and Voting Rights Composing the Capital). It explicitly provides a table detailing the total number of shares and voting rights as of a specific date (February 28, 2023), referencing French regulatory articles (AMF General Regulation and Commercial Code). This content directly relates to changes in the capital structure or significant shareholdings/voting power, which aligns best with either 'Share Issue/Capital Change' (SHA) or 'Major Shareholding Notification' (MRQ). Since it is a mandatory monthly disclosure of the total share count and voting rights, it is a specific type of capital/share structure update. Given the options, 'SHA' (Share Issue/Capital Change) is the most appropriate fit for a formal disclosure of the total share count and voting rights, as it reflects the current capital base. It is not a Director's Dealing (DIRS) or a general regulatory filing (RNS).
2023-03-06 French
MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated March 6th, 2023, providing monthly information regarding the total number of voting rights and shares as of February 28, 2023. This specific disclosure is mandated by French financial regulations (AMF General Regulation and Commercial Code). This type of regular disclosure concerning share capital structure and voting rights does not fit neatly into the primary financial report categories (10-K, IR, ER). It is a specific regulatory update related to ownership/capital structure. While it touches upon share capital, it is not a general capital change announcement (SHA) or a director's dealing (DIRS). It is a mandatory periodic disclosure of share structure. Given the options, this type of mandatory periodic disclosure about the total number of shares and voting rights is best categorized as a general Regulatory Filing (RNS), as it is a specific regulatory requirement that doesn't match the other detailed categories like DIV, NAV, or DVA (which is for voting *results*). The document length is short (2416 chars), but it contains the full required data, not just an announcement of a report.
2023-03-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.